---

Program for Research in Smokers

with Mental Illness

(PRISM)

---

Active Grant Support in PRISM Program

National Institute on Drug Abuse (NIDA), "Nicotinic Receptors and Cognitive Function in Schizophrenia", R01-DA-14039 (Tony P. George, M.D., P.I.), 3/1/01-2/28/04 (no cost extension, 3/1/04-2/28/05), $627,621.

National Institute on Drug Abuse, "Optimizing Treatments for Schizophrenic Smokers", R01-DA-13672 (Tony P. George, M.D., P.I.), 9/1/01-5/31/05, $847,800.

The Patrick and Catherine Weldon Donaghue Medical Research Foundation (Hartford, CT), Clinical and Community Health Issues Award, "Nicotinic Receptor Antagonist Augmentation of SSRI Antidepressants" (PI: Tony P. George, M.D.), 1/1/03-12/31/05, $236,722.

National Institute on Drug Abuse, "Selegiline and Smoking Cessation", 1R01-DA-15757-01A1, PI: Tony P. George, M.D., 7/1/04-3/31/08, $1,429,682.

National Institute on Drug Abuse, "Translational Studies on Smoking and Schizophrenia", 1K02-DA-16611-01A1, PI: Tony P. George, M.D., 4/1/04-3/31/09, $653,458.

NARSAD 2005 Young Investigator Award, "Effects of Atomoxetine and Smoking on Cognitive Function in Schizophrenia", PI: Kristi A. Sacco, Psy.D., 7/1/05-6/30/07, $60,000.00.

NARSAD 2005 Independent Investigator Award, “Effects of Galantamine on Neurocognitive Deficits in Smokers and Non-Smokers with Schizophrenia”, PI: Tony P. George, M.D., 9/15/05-9/14/07, $99,391.00.